Scout | SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

The National Cancer Institute is offering additional funding for small businesses with previously funded cancer-related projects to help them move towards commercialization. This opportunity is for projects that were funded under Phase II SBIR or STTR awards from any federal agency. The goal is to encourage partnerships with third-party investors to support the costly process of bringing new p…

Source

Agency: National Institutes of Health

Program: SBIR

Phase: Phase II

Dates

Open for Submission: April 23, 2024

Opportunity Released: April 23, 2024

Submission Deadline: August 21, 2024

Application Window Closes: August 21, 2024

Keywords

cancer-relevant technologies

commercialization

SBIR Phase IIB

small business concerns

National Cancer Institute

technology development

federal funding

third-party investors

clinical trials

STTR awards

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers